Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample

被引:3
作者
Radestig, Maya Arvidsson [1 ,2 ]
Skoog, Ingmar [1 ,2 ,3 ]
Skillback, Tobias [1 ,2 ]
Zetterberg, Henrik [2 ,4 ,5 ,6 ,7 ]
Kern, Jurgen [1 ]
Zettergren, Anna [1 ,2 ]
Andreasson, Ulf [2 ,4 ]
Wetterberg, Hanna [1 ,2 ]
Kern, Silke [1 ,2 ,3 ]
Blennow, Kaj [2 ,4 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neuropsychiat,Epidemiol Unit, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Psychiat Cognit & Old Age Psychiat, Gothenburg, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden
[5] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England
[6] UK Dementia Res Inst UCL, London WC1N 3BG, England
[7] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
基金
美国国家卫生研究院; 欧盟地平线“2020”; 欧洲研究理事会;
关键词
Alzheimer's disease; Cerebrospinal fluid; CSF; biomarkers; Neurolfilament light; NfL; Neurogranin; ALZHEIMERS-DISEASE; NEUROFILAMENT LIGHT; TAU; NEUROGRANIN; DEMENTIA; PROTEIN; BRAIN; A-BETA(1-42); ASSOCIATION; MARKER;
D O I
10.1186/s13195-023-01193-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundNeurofilament light (NfL) and neurogranin (Ng) are promising candidate AD biomarkers, reflecting axonal and synaptic damage, respectively. Since there is a need to understand the synaptic and axonal damage in preclinical Alzheimer's disease (AD), we aimed to determine the cerebrospinal fluid (CSF) levels of NfL and Ng in cognitively unimpaired elderly from the Gothenburg H70 Birth Cohort Studies classified according to the amyloid/tau/neurodegeneration (A/T/N) system.MethodsThe sample consisted of 258 cognitively unimpaired older adults (age 70, 129 women and 129 men) from the Gothenburg Birth Cohort Studies. We compared CSF NfL and Ng concentrations in A/T/N groups using Student's T-test and ANCOVA.ResultsCSF NfL concentration was higher in the A-T-N+ group (p=0.001) and the A-T+N+ group (p=0.006) compared with A-T-N-. CSF Ng concentration was higher in the A-T-N+, A-T+N+, A+T-N+, and A+T+N+ groups (p<0.0001) compared with A-T-N-. We found no difference in NfL or Ng concentration in A+ compared with A- (disregarding T- and N- status), whereas those with N+ had higher concentrations of NfL and Ng compared with N- (p<0.0001) (disregarding A- and T- status).ConclusionsCSF NfL and Ng concentrations are increased in cognitively normal older adults with biomarker evidence of tau pathology and neurodegeneration.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease
    Perneczky, Robert
    Alexopoulos, Panagiotis
    ALZHEIMERS & DEMENTIA, 2014, 10 (05) : S425 - +
  • [42] Amyloid β42 and Total Tau Levels in Cerebrospinal Fluid Associate with Survival in an 85-Year-Old Population-Based Cohort Followed until Death
    Ribbe, Mats
    Kern, Silke
    Hansson, Anne Borjesson
    Ostling, Svante
    Zetterberg, Henrik
    Blennow, Kaj
    Skoog, Ingmar
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2019, 47 (1-2) : 114 - 123
  • [43] Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors
    Rivero-Santana, Amado
    Ferreira, Daniel
    Perestelo-Perez, Lilisbeth
    Westman, Eric
    Wahlund, Lars-Olof
    Sarria, Antonio
    Serrano-Aguilar, Pedro
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (02) : 625 - 644
  • [44] CHROMOGRANIN-A IN CEREBROSPINAL-FLUID - A BIOCHEMICAL MARKER FOR SYNAPTIC DEGENERATION IN ALZHEIMERS-DISEASE
    BLENNOW, K
    DAVIDSSON, P
    WALLIN, A
    EKMAN, R
    DEMENTIA, 1995, 6 (06): : 306 - 311
  • [45] No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients
    Madlyne Becker
    Clotilde Latarche
    Emilie Roman
    Marc Debouverie
    Catherine Malaplate-Armand
    Francis Guillemin
    BMC Neurology, 15
  • [46] Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers
    Montembeault, Maxime
    Brambati, Simona M.
    Lamari, Foudil
    Michon, Agnes
    Samri, Dalila
    Epelbaum, Stephane
    Lacomblez, Lucette
    Lehericy, Stephane
    Habert, Marie-Odile
    Dubois, Bruno
    Kas, Aurelie
    Migliaccio, Raffaella
    NEUROIMAGE-CLINICAL, 2018, 20 : 1018 - 1025
  • [47] Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease
    Madhurima Chatterjee
    Marta Del Campo
    Tjado H. J. Morrema
    Matthijs de Waal
    Wiesje M. van der Flier
    Jeroen J. M. Hoozemans
    Charlotte E. Teunissen
    Alzheimer's Research & Therapy, 10
  • [48] Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population
    Xie, Qiang
    Ni, Ming
    Gao, Feng
    Dai, Lin-Bin
    Lv, Xin-Yi
    Zhang, Yi-Fan
    Shi, Qin
    Zhu, Xing-Xing
    Xie, Ji-Kui
    Shen, Yong
    Wang, Shi-Cun
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (10): : 1558 - 1565
  • [49] Comparative analysis of Elecsys and ELISA for differentiating amyloid-PET status in a Korean memory clinic based on cerebrospinal fluid biomarkers
    Park, Sun Ah
    An, Young-Sil
    Park, Yong-Jin
    Lee, Ji-Yeong
    Jeon, Hyuna
    Kim, Yoon Seob
    Lee, Keun
    Sun, Kyunghwa
    Lee, Sun Min
    Moon, So Young
    JOURNAL OF ALZHEIMERS DISEASE, 2025, 104 (01) : 232 - 244
  • [50] Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer's disease
    Gouilly, Dominique
    Vrillon, Agathe
    Bertrand, Elsa
    Goubeaud, Marie
    Catala, Helene
    Germain, Johanne
    Ainaoui, Nadera
    Rafiq, Marie
    Nogueira, Leonor
    Mouton-Liger, Francois
    Planton, Melanie
    Salabert, Anne-Sophie
    Hitzel, Anne
    Meligne, Deborah
    Jasse, Laurence
    Sarton, Benjamine
    Silva, Stein
    Lemesle, Beatrice
    Peran, Patrice
    Payoux, Pierre
    Thalamas, Claire
    Paquet, Claire
    Pariente, Jeremie
    NEUROIMAGE-CLINICAL, 2024, 43